Seeking Alzheimer's clues from few who escape genetic fate
Scientists are digging into why a few people escape the rarest form of Alzheimer's, which is inherited and strikes young
The Independent UK ·
Get all your news in one place.
100's of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100's of premium titles. One news app.
The Latest Breaking News from Richard Hodes
Finally, a new drug slows Alzheimer’s, but is it worth the price for modest benefit?
Leqembi can slow early progression by months but has safety concerns. Most patients will likely have to wait months to get the IV drug, which will cost about $26,500 a year. Insurers need to decide whether and how much to cover it. Medicare isn’t expected to pay for it until…
Chicago Sun-Times ·
EXPLAINER: New drug slows Alzheimer's but comes with caveats
A new Alzheimer’s drug is hitting the market with experts voicing a lot of caution
The Independent UK ·
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Coverage From
The Independent UK
Chicago Sun-Times
Organisations
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
100+ trusted global sources.
